Lithium's antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies

Colleen E Kovacsics1, Irving I Gottesman, Todd D Gould

  • 1Department of Psychiatry, Mood and Anxiety Disorders Program, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Insights

Lithium effectively reduces suicide risk in major mental disorders. Understanding its anti-aggression and anti-impulsivity effects may reveal mechanisms for developing better suicide prevention strategies.

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Lithium is a key treatment for bipolar disorder and depression, significantly reducing suicide risk.
  • The precise mechanisms behind lithium's antisuicidal effects remain unknown, hindering the development of new treatments.
  • Studying suicide is complex due to ethical and modeling limitations in humans and animals.

Purpose of the Study:

  • To explore the endophenotype approach for understanding suicide.
  • To review evidence linking aggression and impulsivity to suicide.
  • To examine lithium's effects on aggression and impulsivity in humans and rodents.

Main Methods:

  • Review of existing literature on suicide, endophenotypes, and lithium.
  • Analysis of aggression and impulsivity as potential endophenotypes for suicide.
  • Examination of lithium's impact on aggression and impulsivity in human and animal studies.

Main Results:

  • Aggression and impulsivity are strongly associated with suicide risk.
  • Lithium demonstrates anti-aggressive and anti-impulsive effects in both human and rodent models.
  • These effects suggest a potential pathway for understanding lithium's antisuicidal actions.

Conclusions:

  • Investigating lithium's anti-aggression and anti-impulsivity mechanisms is crucial.
  • Elucidating these mechanisms can advance the understanding of suicidal behavior.
  • This research may guide the development of novel suicide-reducing therapeutics.